RAYMOND JAMES TRUST N.A. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES TRUST N.A. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$2,317,000
+2.2%
53,226
+2.3%
0.08%
+18.6%
Q1 2022$2,267,000
+2.0%
52,046
+3.3%
0.07%
+6.1%
Q4 2021$2,222,000
+14.0%
50,379
-1.2%
0.07%
+1.5%
Q3 2021$1,949,000
-0.4%
50,994
+3.8%
0.06%0.0%
Q2 2021$1,956,000
+7.9%
49,123
-3.3%
0.06%
+3.2%
Q1 2021$1,812,000
-15.0%
50,785
-12.3%
0.06%
-23.2%
Q4 2020$2,131,000
-25.2%
57,889
-23.5%
0.08%
-33.3%
Q3 2020$2,849,000
-10.7%
75,683
-3.2%
0.12%
-20.1%
Q2 2020$3,189,000
+0.1%
78,194
-7.1%
0.15%
-18.5%
Q1 2020$3,187,000
-19.2%
84,135
+0.2%
0.19%
+0.5%
Q4 2019$3,945,000
+10.3%
83,957
+0.2%
0.19%
+2.2%
Q3 2019$3,577,000
+9.6%
83,828
+2.8%
0.18%
+2.2%
Q2 2019$3,265,000
-7.7%
81,573
-3.6%
0.18%
-11.8%
Q1 2019$3,538,000
+9.4%
84,652
-0.0%
0.20%
-1.9%
Q4 2018$3,235,000
-12.8%
84,683
-8.3%
0.21%
-0.5%
Q3 2018$3,711,000
-4.5%
92,383
-4.1%
0.21%
-11.4%
Q2 2018$3,884,000
+2.9%
96,349
-0.3%
0.24%
-9.6%
Q1 2018$3,774,000
+14.2%
96,597
+3.7%
0.26%
+17.6%
Q4 2017$3,304,000
-11.4%
93,139
+1.4%
0.22%
-16.9%
Q3 2017$3,728,000
+2.0%
91,829
+8.3%
0.27%
-2.2%
Q2 2017$3,655,000
-34.5%
84,756
-35.9%
0.27%
-35.6%
Q1 2017$5,576,000
+13.2%
132,266
+3.4%
0.42%
+8.2%
Q4 2016$4,924,000
-16.8%
127,865
-6.9%
0.39%
-23.0%
Q3 2016$5,921,000
-1.4%
137,289
-0.9%
0.51%
-3.8%
Q2 2016$6,007,000
+10.4%
138,605
+3.3%
0.53%
+4.3%
Q1 2016$5,440,000
+86.8%
134,156
+85.9%
0.51%
+88.5%
Q4 2015$2,912,000
+12.6%
72,160
+7.2%
0.27%
-7.6%
Q3 2015$2,587,000
-15.2%
67,292
-8.1%
0.29%
-9.9%
Q2 2015$3,050,000
-4.8%
73,230
+5.5%
0.32%
-5.8%
Q1 2015$3,203,000
+15.7%
69,399
+7.1%
0.34%
+15.1%
Q4 2014$2,769,000
-10.8%
64,814
-4.1%
0.30%
-16.3%
Q3 2014$3,106,000
-1.1%
67,552
+15.0%
0.36%
-1.1%
Q2 2014$3,142,000
+17.0%
58,750
+16.9%
0.36%
+9.1%
Q1 2014$2,685,000
-28.5%
50,262
-28.6%
0.33%
-33.1%
Q4 2013$3,757,000
+7.9%
70,380
+1.4%
0.49%
-8.0%
Q3 2013$3,483,000
+5.5%
69,421
+5.0%
0.54%
-0.7%
Q2 2013$3,302,00066,0870.54%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders